Acadia Healthcare Company, Inc. (ACHC) Stock
Key stats
- Market cap
- $2.97B
- Price / Earnings ratio
- -2.6x
- EPS (TTM)
- $1.87
- Volume
- Loading
- 52-week high
- $35.83
- 52-week low
- $11.43
- Next earnings report
- 4 Nov 2026
Source: third-party data provider, as of October 24, 2026
Compare with ACHC
Recent news

Acadia Healthcare Announces Date for Third Quarter 2026 Earnings Release
Acadia Healthcare Announces Date for Third Quarter 2026 Earnings Release
ACHC

Acadia Healthcare (ACHC) Upgraded to Buy: Here's What You Should Know
Acadia Healthcare (ACHC) Upgraded to Buy: Here's What You Should Know
ACHC

Is Acadia Healthcare (ACHC) Outperforming Other Medical Stocks This Year?
Is Acadia Healthcare (ACHC) Outperforming Other Medical Stocks This Year?
ACHC

Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement
Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement
ACHC
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 63.40
- MACD 12/26/9
- 0.76
- EMA 9 of MACD
- 0.48
- MACD histogram
- 0.27
- SMA 50
- $28.91
- Price above SMA 50
- EMA 50
- $29.36
- Price above EMA 50
- SMA 200
- $25.28
- Price above SMA 200
- EMA 200
- $24.90
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 22, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 3 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $0.60 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Acadia Healthcare Announces Date for Third Quarter 2026 Earnings Release
Acadia Healthcare Announces Date for Third Quarter 2026 Earnings Release
ACHC

Acadia Healthcare (ACHC) Upgraded to Buy: Here's What You Should Know
Acadia Healthcare (ACHC) Upgraded to Buy: Here's What You Should Know
ACHC

Is Acadia Healthcare (ACHC) Outperforming Other Medical Stocks This Year?
Is Acadia Healthcare (ACHC) Outperforming Other Medical Stocks This Year?
ACHC

Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement
Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement
ACHC

Acadia Healthcare Jumps 100% YTD on Improving Outlook and Expansion
Acadia Healthcare Jumps 100% YTD on Improving Outlook and Expansion
ACHC

How Acadia Healthcare Is Turning Capacity Growth Into Cash Flow
How Acadia Healthcare Is Turning Capacity Growth Into Cash Flow
ACHC

Zacks Industry Outlook Tenet, Acadia and Community Health Systems
Zacks Industry Outlook Tenet, Acadia and Community Health Systems
ACHC

3 Hospital Stocks Riding Strong Demand and Improved Efficiency
3 Hospital Stocks Riding Strong Demand and Improved Efficiency
ACHC

Acadia Healthcare to Participate in 2026 Jefferies Healthcare Services and Technology Conference
Acadia Healthcare to Participate in 2026 Jefferies Healthcare Services and Technology Conference
ACHC

Acadia Healthcare Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Acadia Healthcare Company, Inc. - ACHC
Acadia Healthcare Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Acadia Healthcare Company, Inc. - ACHC
ACHC
News tone: automated (AI) classification of the article's content, not a price prediction.
About Acadia Healthcare Company, Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Ms. Debra K. Osteen | CEO & Director | 1956 |
| Mr. David M. Duckworth | Interim Chief Financial Officer | 1980 |
| Mr. Brian P. Farley Esq., J.D. | Executive VP, General Counsel & Secretary | 1970 |
| Mr. Timothy Sides | Senior Vice President of Operations Finance | 1978 |
| Mr. Patrick Thomas Feeley C.F.A., CPA | Senior Vice President of Investor Relations | — |
| Mr. Jeffrey Woods | Operations Group President | — |
| Steve Quigley | Group President of Specialty Division | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of October 24, 2026
Technical indicators
- RSI 14
- 63.40
- MACD 12/26/9
- 0.76
- EMA 9 of MACD
- 0.48
- MACD histogram
- 0.27
- SMA 50
- $28.91
- Price above SMA 50
- EMA 50
- $29.36
- Price above EMA 50
- SMA 200
- $25.28
- Price above SMA 200
- EMA 200
- $24.90
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 22, 2026. Technical data, not a recommendation.
Analyst views
3 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $32.00
- Average
- $34.67
- High
- $39.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +10.3 | -11.1 | +12.9 | |||||||||
| 2022 | -12.7 | +6.9 | +8.1 | +1.0 | +6.4 | -1.9 | +15.8 | +0.0 | -3.9 | +0.3 | +11.0 | -6.0 |
| 2023 | +3.1 | -13.7 | -2.8 | -0.4 | +0.2 | +12.4 | -0.2 | -1.8 | -9.3 | +5.6 | -0.7 | +5.3 |
| 2024 | +5.0 | +2.1 | -5.7 | -2.8 | -5.6 | -1.4 | -3.2 | +10.6 | -18.9 | -31.6 | -3.3 | -6.7 |
| 2025 | +10.6 | -33.1 | +3.6 | -21.8 | -0.6 | +4.9 | -7.3 | +8.9 | +5.6 | -12.4 | -19.3 | -15.7 |
| 2026 | -5.9 | +77.4 | -0.2 | +9.4 | -16.7 | +26.7 | -5.2 | -9.9 | -2.7 | +18.4 |



